We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current RENX market cap is 26.48M. The company's latest EPS is USD -0.4626 and P/E is -0.57.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 339k | 1.49M | 2.97M | 3.4M |
| Operating Income | -6.96M | -10.8M | -34.72M | -57.24M | -32.19M |
| Net Income | -5.98M | -9.25M | -31.01M | -56.73M | -46.22M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.92M | 41.3M | 102.58M | 63.26M | 42.12M |
| Total Liabilities | 755k | 5.34M | 7.48M | 20.09M | 23.66M |
| Total Equity | 28.17M | 35.96M | 95.1M | 43.17M | 18.45M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.42M | -10.06M | -24.63M | -45.75M | -32.67M |
| Investing | -13.05M | -849k | -741k | -694k | N/A |
| Financing | 26.74M | 16.85M | 77.24M | 25.52M | 15.12M |
| Market Cap | 26.48M |
| Price to Earnings Ratio | -0.57 |
| Price to Sales Ratio | 7.77 |
| Price to Cash Ratio | 1.07 |
| Price to Book Ratio | 1.44 |
| Dividend Yield | - |
| Shares Outstanding | 99.93M |
| Average Volume (1 week) | 97.66k |
| Average Volume (1 Month) | 180.59k |
| 52 Week Change | -71.35% |
| 52 Week High | 145.00 |
| 52 Week Low | 10.25 |
| Spread (Intraday) | 1 (3.7%) |
| Company Name | Renalytix Plc |
| Address |
finsgate london EC1V 9EE |
| Website | https://renalytix.com |
| Industry | services, nec (8999) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
